Biotech and Beer is Coming to the VA Bio+Tech Park
The Central Virginia region is home to an amazing network of biotech, pharma, medical device, healthcare and life science professionals. We also happen to live
The Central Virginia region is home to an amazing network of biotech, pharma, medical device, healthcare and life science professionals. We also happen to live
On a picture-perfect spring day, hundreds of members of the VA Bio+Tech Park took a lunch break with their neighbors in the shady confines of
Activation Capital, an innovation ecosystem development organization, announced plans to develop the 102,000-square foot Innovation Center in the Bio+Tech Park in Richmond, Virginia.
The latest funding highlights a series of investments into the Virginia Bio+Tech Park, complementing the City of Richmond’s investment into its Innovation District vision.
Tympanogen, a medical device startup based at the VA Bio+Tech Park in Richmond, VA, was awarded a $1.48 million Small Business Innovation Research (SBIR) grant from the National Institute on Deafness and Other Communication Disorders (NIDCD).
WynnVision, a biomedical nanofilms company located in the Bio+Tech Center, received an NIH SBIR FastTrack award from the National Heart, Lung, and Blood Institute.
Governor Northam announced the recipients of the 2018 CRCF awards given to exciting advancements in six industries: biosciences and medical technologies, cyber security, clean energy, water quality, data analytics and unmanned systems.
Since its creation, the VA Bio+Tech Park has supported over 120 companies.
The Virginia Biotechnology Research Park was named as “Best of R&D in Virginia” and Richmond named “Best Locations for Biosciences in Virginia” in the most recent issue of Southern Business and Development.
Invests Over $26,000 Worth of Equipment to the Innovation Ecosystem RICHMOND – Altria’s Center for Research and Technology made a significant donation valued at over